State Street’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.3M Sell
2,830,074
-257,021
-8% -$4.11M ﹤0.01% 1728
2025
Q1
$52.8M Buy
3,087,095
+389,573
+14% +$6.66M ﹤0.01% 1597
2024
Q4
$66.8M Sell
2,697,522
-324,820
-11% -$8.05M ﹤0.01% 1573
2024
Q3
$86.2M Buy
3,022,342
+303,386
+11% +$8.65M ﹤0.01% 1410
2024
Q2
$71.8M Sell
2,718,956
-922,951
-25% -$24.4M ﹤0.01% 1461
2024
Q1
$118M Buy
3,641,907
+425,531
+13% +$13.7M 0.01% 1205
2023
Q4
$136M Sell
3,216,376
-252,241
-7% -$10.6M 0.01% 1094
2023
Q3
$133M Buy
3,468,617
+234,448
+7% +$9M 0.01% 995
2023
Q2
$61.4M Sell
3,234,169
-733,436
-18% -$13.9M ﹤0.01% 1534
2023
Q1
$61.5M Buy
3,967,605
+854,662
+27% +$13.3M ﹤0.01% 1506
2022
Q4
$55.3M Buy
3,112,943
+2,234,342
+254% +$39.7M ﹤0.01% 1558
2022
Q3
$4.9M Sell
878,601
-14,079
-2% -$78.6K ﹤0.01% 3071
2022
Q2
$3.48M Buy
892,680
+56,938
+7% +$222K ﹤0.01% 3272
2022
Q1
$4.61M Sell
835,742
-1,947,052
-70% -$10.7M ﹤0.01% 3222
2021
Q4
$23.7M Sell
2,782,794
-1,329,000
-32% -$11.3M ﹤0.01% 2347
2021
Q3
$35.7M Sell
4,111,794
-278,843
-6% -$2.42M ﹤0.01% 2045
2021
Q2
$46.4M Buy
4,390,637
+774,877
+21% +$8.19M ﹤0.01% 1901
2021
Q1
$58M Buy
3,615,760
+1,746,740
+93% +$28M ﹤0.01% 1631
2020
Q4
$86.3M Buy
1,869,020
+717,555
+62% +$33.1M 0.01% 1259
2020
Q3
$40.5M Buy
1,151,465
+819,890
+247% +$28.9M ﹤0.01% 1606
2020
Q2
$8.07M Buy
+331,575
New +$8.07M ﹤0.01% 2537